Breathe Well Live Well
|
Harvard Clinical Research Institute Initiates Comparative Effectiveness Study …
Business Wire (press release) Tiotropium) Study, the purpose of which is to investigate whether Black patients with asthma are more likely to experience adverse outcomes as a result of long-acting beta-agonist (LABA) therapy. The BELT study was funded by a grant from the Agency for … |
View full post on asthma – Google News
|
Harvard Clinical Research Institute Initiates Comparative Effectiveness Study …
Genetic Engineering News Tiotropium) Study, the purpose of which is to investigate whether Black patients with asthma are more likely to experience adverse outcomes as a result of long-acting beta-agonist (LABA) therapy. The BELT study was funded by a grant from the Agency for … |
View full post on asthma – Google News
|
Forest Labs, Allergy Asthma Research Institute sign up with SAFE-BioPharma …
Pharmaceutical Business Review Forest Laboratories and Allergy Asthma Research Institute have joined SAFE-BioPharma Association to have access to the SAFE-BioPharma digital identity and signature standard for the verification and management of digital identities involved in … Forest Laboratories and Allergy Asthma Research Institute Join SAFE-BioPharma … |
View full post on asthma – Google News
|
Marion Institute: “Allergies and Asthma”
Wanderer (blog) The Biological Medicine Network (BMN), a program of the Marion Institute, is pleased to offer a free public lecture “Allergies and Asthma – Healing with … |
View full post on asthma – Google News
Today we congratulate the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and the people of South Africa on the positive findings from the CAPRISA 004 microbicide study, which marks a significant milestone both for the microbicide research field and HIV prevention as a whole.
View full post on National Institutes of Health (NIH) News Releases